[1] Sehomig M,Eisenhandt A,Ritz E.The microinflammatory state of uremia[J]. BloodPurif,2000,18(4):327-332.

[2] Stenvinkel P,Heimburger O,Paulter F,et al.Strong assoeiation between malnutrition,inflammation and atheroselerosis in chronic renal failure[J].Kidney Int,1999,55(5):1899-911.

[3] Gerdes N,Sukhova G K,Libby P,et al.Expression of interleukin(IL)-18 and Functional IL-18 receptor on human vascular endothelial cells,smooth muscle cells,and macrophages:implications for atherogenesis[J].J Exp Med, 2002,195(2):245-257.

[4] Panieh I V,Miglior M,De Pietro S,et al.The link of biocompatibility to cytokine Production[J].Kidney Int Supple,2000,76:596-603.

[5] Ariei M,Walls J.End-stages renal disease,atherosclerosis,and cardiovascular mortality is C-reactive protein the missing link[J]. Kidney Int,2001,2:407-414.

[6] George A,Kaysen G A.Role of inflamation and its treatment in ESRD patients [J]. Blood Purif,2000,18:337-342.

[7] Muntner P,Hamml L,Kusek J W,et al.The Prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease[J]. Ann Intern Med,2004,140:9-17.

[8] Owen W F,Lowrie E G.C-reactive Protein as an outcome Predietor for maintenance hemodialysis patients[J].Kidney Int,1998,54(2):627-636.

[9] Takayama F,Miyazaki T,Aoyama l,et al.Involvement of interleukin-8 in Dialysis related arthritis[J]. Kidney Int,1998,53(4):1007-1013.

[10] Jourde-Chiche N,Dou L,Cerini C,et al.Protein-bound toxins-update 2009[J].Semin Dial,2009, 22(4):334-339.

[11] Gerdes N,Sukhova G K,Libby P,et al.Expression of interleukin(IL)-18 and functional IL-18 receptor on human vascular endothelial cells,smooth musele cells,and macrophages:implications for atherogenesis[J].J ExP Med,2002,195(2):245-257.

[12] 侯凡凡.对尿毒症的新认识[J].中华肾脏病杂志,2003,19(2):69-70.

[13] Ariei M,Walls J. End-stages renal disease,atherosclerosis,and cardiovascular mortality is C-reactive protein the missing link[J]. Kidney Int,2001,2:407-414.

[14] Kuo H L,Chou C Y,Liu Y L,et al.Reduction of Pro-inflammatory cytokines Through hemodiafiltration[J].Ren Fail,2008,30(8):796-800.

[15] Muntner P,Hamml L,Kusekj W,et al.The Prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease [J]. Ann Intern Med,2004,140:9-17.

[16] 梁 敏,王 力,侯凡凡,等.单核细胞活化与终末期肾病炎性反应状态的关系[J].第一军医大学学报,2003,23(8):751-754.

[17] Quarles L D, Sherrard D J, Adler S, et al.The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end stage renal disease[J].J Am Soc Nephrol,2003,14(3):575-583.

[18] Strazecki P,Adamowicz A,Nartowicz E,et al.Parathormon,calicium,phosphorus,and left ventricular structure and function in normotensive hemodialysis patients[J].Ren Fail, 2001, 23(1):115-126.

[19] Guo Y S, Yuan W J, Wang L,et al.Parathyroid hormone -potentiated connective tissue growth factor expression in human renal proximal tubular cells through activating the MAPK and NF-κB signalling pathways [J]. Nephrol Dial Transplant ,2011,26:839-847.

[20] 王碧飞,祝胜郎,杨京新,等.活性维生素D₃治疗对维持性血液透析患者微炎性反应的影响谢础能[J].中国临床药理学与治疗学,2009,14(6):686-690.

[21] Shuvy M, Abedat S, Beeri R,et al.Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats[J].Cardiovascular Research,2008,79(3):492-499.

[22] 蒋宁君,谢佳芯,毕新岭,等.重组人甲状旁腺素(1234)对角质形成细胞分泌IL-6和IL-8的影响[J].中国皮肤性病学杂志,2009,23(6):341-343.

[23] Almqvist E G, Bondeson A G , Bondeson L,et al.Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism[J].Scand J Clin Lab Invest, 2011,71(2):139-144.

[24] 张晓东, 张建荣, 朱 愿,等. 维持性血液透析患者微炎症状态与颈动脉内中膜厚度进展的相关性研究[J]. 武警医学,2012,13(2):1056-1059.